Every monsoon and winter, hospitals see a rise in babies struggling with severe cough, breathing trouble, or symptoms that seem like an upper respiratory tract infection or pneumonia. Many parents ...

Respiratory syncytial virus (RSV) is spreading across the country, but it’s not too late to take steps to protect babies from severe illness associated with the virus.

• RSV is the leading cause of infant hospitalization in the U.S. • Health officials urge vaccination for pregnant women, seniors, and people with medical risks. • Cases are climbing nationwide as flu ...

Whooping cough cases in Mississippi have reached a 16-year high, with 139 cases reported in 2025. Children ages 5-17 and infants under one year old are the most affected by the whooping cough outbreak ...

INDIANAPOLIS (WISH) — This week, it was reported that the FDA is reviewing the safety of two drugs, Clesrovimab (Enflonsia) and Nirsevimab (Beyfortus), both approved for the prevention of RSV in ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. While pregnant with her third child ...

Over the last few years, the U.S. has experienced a troubling resurgence of pertussis, also known as whooping cough. During the COVID-19 pandemic, masking and social-distancing dramatically reduced tr ...

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...

PHOENIX — Federal health officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, a respiratory virus that routinely impacts pediatric wards across ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...